ArticleJournal of cutaneous pathology2026
Dermal-Based Spindle Cell Lipoma: A Case Series of 12 Patients.
Article in Journal of cutaneous pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Spindle cell lipoma (SCL) is a benign adipocytic neoplasm that typically presents as a subcutaneous mass in the "shawl" distribution of older men. This classic prototype is well recognized; however, the clinicopathologic features of dermal variants remain incompletely characterized. This case series includes 12 dermally located SCLs from our archives. Morphologic features were evaluated by consensus, and immunohistochemistry for RB1 and CD117 was performed on available tissue. The cohort included eight men and four women, with a mean age of 55 years. Half of the cases (50%) arose in atypical locations, most commonly the face. Histologically, tumors frequently deviated from the classic morphology: 50% were fat-free or fat-poor, 83% were poorly circumscribed, 33% showed myxoid change, and 16% displayed pseudoangiomatous features. All cases where immunohistochemistry could be performed showed RB1 loss (6 cases) and abundant CD117-positive mast cells (7 cases). Dermal SCL differs from the classic subcutaneous prototype. They are more likely to affect women, occur in atypical sites, be poorly circumscribed, and have fat-free or fat-poor morphologies. These deviations from the prototypical SCL illness script are diagnostically challenging, since they mimic other spindle cell neoplasms, such as neurofibroma, PRRX1-rearranged fibroblastic tumor, and a variety of spindle cell lesions that lack RB1 expression. CD117-positive mast cells may be helpful diagnostically.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.